Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Enhanced Recovery After Cesarean: Scheduled Post-operative Medication: a Randomized Controlled Trial

NCT04612920 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT04612920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04612920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Enhanced Recovery After Cesarean: Scheduled Post-operative Medication: a Randomized Controlled Trial
Lead sponsor
University of Oklahoma
Phase
Phase 1
Overall status
Completed
Start date
December 12, 2020
Completion date
March 8, 2023
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cesarean section complications